You're offline — showing cached data
BibaMoney TVIJO AIOS NETWORK

Pfizer Inc.

PFE · NYSE
Healthcare · Drug Manufacturers - General
$30.03 -1.28% today
—Market cap
—P/E (TTM)
—Net margin
—Revenue / share

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical company that researches, develops, manufactures, markets, and distributes medicines and vaccines worldwide. Its portfolio spans therapeutic areas such as cardiovascular health, women's health, oncology, immunology, and anti-infectives, with key products including Eliquis, the Premarin family, Ibrance, Xtandi, and Retacrit. Pfizer also produces sterile injectables, small molecule drugs, biologics, immunotherapies, and biosimilars, and operates through divisions that include biopharma and consumer healthcare-related operations.

Why it matters

Pfizer is one of the largest pharmaceutical companies by revenue and maintains a broad global manufacturing, distribution, and research footprint. Its scale, diverse product portfolio, and pipeline of vaccines and therapies make it a widely followed name in the healthcare sector. Investors and traders monitor Pfizer for its role in global drug development, its exposure to patent expirations and generic competition, and its participation in vaccine and antiviral markets.

Company site ↗

How we research PFE

Fundamentals like the ones above feed our fundamental screen — EPS acceleration, ROE and momentum∧quality — the one research class that survives walk-forward in our testing. We don’t issue price targets or buy/sell calls: see /edge for how rigorously (and how rarely) anything passes. This page is market data and research, not investment advice.

Data updated 18:00 UTC, 26 Oct 2026 · source: Financial Modeling Prep via Tvijo AIOS.